← Back
$LVTX All transactions

LAVA Therapeutics NV

D

$ Value

$0

Shares

33,390

Price

$0

Filed

Nov 17

Insider

Name

Dhingra Kapil

Title

CIK

0001456849

Roles

Director

Transaction Details

Transaction Date

2025-11-13

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Disposed of pursuant to that certain Purchase Agreement, dated August 3, 2025, by and between the Issuer and XOMA Royalty Corporation (as amended, the " Purchase Agreement") in exchange for (i) $1.04 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share. | This option was cancelled pursuant to that certain Purchase Agreement in exchange for cash and CVRs (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to (i) the excess of $1.04 over the per share exercise price of such option multiplied by the total number of shares underlying such in option and (ii) one CVR per share underlying such in-the-money option.

Filing Info

Accession No.

0001456849-25-000005

Form Type

4

Issuer CIK

0001840748

Dhingra Kapil's History

Date Ticker Type Value
2026-04-01 REPL A $0
2025-12-09 REPL M $6K
2025-12-09 REPL $33K
2025-12-09 REPL M $0
2025-11-13 LVTX D
2025-11-13 LVTX D $0
2025-08-19 CRGX D
2025-06-18 CRGX A $0
2025-06-12 BDTX A $0

Other Insiders at LVTX (90d)

No other insider activity at this issuer in the last 90 days.